Penpulimab Injection
Product Images NDC 83654-105

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Penpulimab (NDC 83654-105). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Akeso Biopharma, Co., Ltd, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Figure 1 Kaplan-meier Curves Of Pfs For Ak105-304 (Figure 1 Kaplan Meier Curves Of Pfs For Ak105 304)

Figure 1 Kaplan-meier Curves Of Pfs For Ak105-304 (Figure 1 Kaplan Meier Curves Of Pfs For Ak105 304)
A Kaplan-Meier curve chart showing the probability of progression-free survival (%) over time in months for two treatment groups: Penpulimab-kcqx plus chemotherapy (blue solid line) and placebo plus chemotherapy (red dashed line). Censored data points are marked with plus signs. The number of patients at risk at various time points is listed for each group below the chart.*
FDA Label Image

Carton Label (Bla 761258 Carton Label Revised 4 23 2025)

Carton Label (Bla 761258 Carton Label Revised 4 23 2025)
Carton packaging label for Penpulimab-kcqx Injection 100 mg/10 mL (10 mg/mL) by Akeso Biopharma Co., Ltd. The label includes the proprietary name, strength, dosage form, instructions indicating it is for intravenous infusion after dilution, manufacturer address in Guangdong, China, and a barcode. The label also contains storage instructions, recommended dosage reference, and symbols indicating single-dose vial and prescription use.*
FDA Label Image

Vial Label (Bla 761258 Vial Label Revised 4 23 2025)

Vial Label (Bla 761258 Vial Label Revised 4 23 2025)
The label for Penpulimab-kcqx Injection displays a strength of 100 mg/10 mL (10 mg/mL) for intravenous infusion after dilution. It instructs pharmacists to dispense the enclosed Medication Guide and indicates it is a single-dose vial. Storage is specified at 2°C to 8°C. The product is manufactured by Akeso Biopharma Co., Ltd.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.